Related Experiment Video
Updated: Jan 29, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Discordance in Antenatal Corticosteroid Use and Resuscitation Following Extremely Preterm Birth
Matthew A Rysavy1, Edward F Bell1, Jay D Iams2
1Department of Pediatrics, University of Iowa, Iowa City, IA.
Insights
Consistent antenatal corticosteroids for extremely preterm infants, especially at 23 weeks gestation, may improve survival and neurodevelopment. This is crucial when resuscitation is planned, reducing discordant care.
Area of Science:
- Neonatal Medicine
- Perinatal Research
- Pediatric Outcomes
Background:
- Extremely preterm birth presents significant challenges for infant survival and neurodevelopment.
- Discordance between antenatal corticosteroid administration and resuscitation efforts complicates care.
- Variations in care practices can impact outcomes for vulnerable neonates.
Purpose of the Study:
- To analyze discordance in antenatal corticosteroid use and resuscitation for extremely preterm infants.
- To investigate the relationship between these practices and infant survival and neurodevelopmental outcomes.
- To model the potential impact of optimizing antenatal corticosteroid use on infant outcomes.
Main Methods:
- A multicenter cohort study involving 4858 infants born between 22-26 weeks gestation.
- Follow-up data on survival and neurodevelopmental outcomes were collected at 18-22 months corrected age.
- Statistical modeling was used to assess the effect of increasing antenatal corticosteroid exposure.
Main Results:
- Discordant care (one intervention without the other) was more common at 22 and 23 weeks gestation compared to 25-26 weeks.
- For 23-week infants receiving resuscitation, increasing antenatal corticosteroid use to 89.2% was projected to improve survival by 7.1% and survival without impairment by 6.4%.
- No significant outcome improvement was projected for 22-week infants due to very low antenatal corticosteroid use in resuscitated infants.
Conclusions:
- Infants born at 23 weeks gestation frequently received resuscitation without antenatal corticosteroids.
- Consistent antenatal corticosteroid administration, when resuscitation is intended, may enhance infant survival and reduce severe impairment.
- Optimizing antenatal corticosteroid use is a critical strategy for improving outcomes in extremely preterm neonates.
Objective:
To describe discordance in antenatal corticosteroid use and resuscitation following extremely preterm birth and its relationship with infant survival and neurodevelopment.
Study Design:
A multicenter cohort study of 4858 infants 22-26 weeks of gestation born 2006-2011 at 24 US hospitals participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, with follow-up through 2013. Survival and neurodevelopmental outcomes were available at 18-22 months of corrected age for 4576 (94.2%) infants. We described antenatal interventions, resuscitation, and infant outcomes. We modeled the effect on infant outcomes of each hospital increasing antenatal corticosteroid exposure for resuscitated infants born at 22-24 weeks of gestation to rates observed at 25-26 weeks of gestation.
Results:
Discordant antenatal corticosteroid use and resuscitation, where one and not the other occurred, were more frequent for births at 22 and 23 but not 24 weeks (rate ratio [95% CI] at 22 weeks: 1.7 [1.3-2.2]; 23 weeks: 2.6 [2.2-3.2]; 24 weeks: 1.0 [0.8-1.2]) when compared with 25-26 weeks. Among infants resuscitated at 23 weeks, adjusting each hospital's rate of antenatal corticosteroid use to the average at 25-26 weeks (89.2%) was projected to increase infant survival by 7.1% (95% CI 5.4-8.8%) and survival without severe impairment by 6.4% (95% CI 4.7-8.1%). No significant change in outcomes was projected for infants resuscitated at 22 weeks, where few (n = 22) resuscitated infants received antenatal corticosteroids.
Conclusions:
Infants born at 23 weeks were more frequently resuscitated without antenatal corticosteroids than other extremely preterm infants. When resuscitation is intended, consistent provision of antenatal corticosteroids may increase infant survival and survival without impairment.
Trial Registration:
ClinicalTrials.govNCT00063063 (Generic Database) and NCT00009633 (Follow-Up Study).
Related Concept Videos
Birth Control Methods
COPD: Management Using Bronchodilators and Corticosteroids
Cardiopulmonary Resuscitation I: Adult
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Absolute and Local Extreme Values
Cardiopulmonary Resuscitation III: AED Use

